Currently, Eagle Pharmaceuticals Inc [EGRX] is trading at $5.14, down -1.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EGRX shares have gain 12.72% over the last week, with a monthly amount glided 7.53%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Eagle Pharmaceuticals Inc [NASDAQ: EGRX] stock has seen the most recent analyst activity on August 10, 2023, when Piper Sandler downgraded its rating to a Underweight and also revised its price target to $17 from $26. Previously, Piper Sandler downgraded its rating to Underweight on August 09, 2023, and dropped its price target to $17. Cantor Fitzgerald downgraded its rating to a Neutral. Piper Jaffray downgraded its rating to a Neutral. Mizuho reiterated a Underperform rating for this stock on March 21, 2018, and upped its price target to $40. In a note dated November 09, 2017, RBC Capital Mkts reiterated an Outperform rating on this stock and revised its target price from $81 to $75.
This stock has fluctuated between a low of $3.21 and a high of $18.16 over the last 52 weeks. Eagle Pharmaceuticals Inc [NASDAQ: EGRX] shares were valued at $5.14 at the most recent close of the market.
Analyzing the EGRX fundamentals
Trailing Twelve Months sales for Eagle Pharmaceuticals Inc [NASDAQ:EGRX] were 257.55M which represents -12.80% decline. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.09 points at the first support level, and at 5.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.23, and for the 2nd resistance point, it is at 5.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Eagle Pharmaceuticals Inc [NASDAQ:EGRX] is 2.16. Also, the Quick Ratio is 1.61, while the Cash Ratio stands at 0.18. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 0.27 and price to earnings (TTM) ratio is 5.65.
Transactions by insiders
Recent insider trading involved Tarriff Scott, CEO, that happened on Nov 01 ’23 when 10925.0 shares were sold. CEO, Tarriff Scott completed a deal on Nov 02 ’23 to sell 10694.0 shares. Meanwhile, CEO Tarriff Scott sold 10734.0 shares on Oct 03 ’23.
